Cancer Drug Resistance is a member of the Committee on Publication Ethics (COPE) and fully adhere to its Code of Conduct and to its Best Practice Guidelines.

Cancer Drug Resistance is a member of and subscribes to the principles of STM. Authors of CDR can reuse a certain quantity of article contents from the chargeable publications of other STM members for free in their submissions to CDR.

Cancer Drug Resistance is a member of ORCID and our MESAs system has been connected with ORCID. After submissions to CDR are published, they will be automatically synchronized to the authors' ORCID accounts if the authors have connected their MESAs accounts with ORCID accounts. CDR's reviewers can choose to synchronize their review records to their ORCID accounts when filling in review reports.

Cancer Drug Resistance is a member of Crossref, which makes research outputs easy to find, cite, link, assess, and reuse.

All submissions to Cancer Drug Resistance are checked for plagiarism by iThenticate.

All published articles in Cancer Drug Resistance are enriched with a record of the current article status.